+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

HCV genotype does not predict sustained virologic response to interferon plus ribavirin in chronic hepatitis C patients with advanced fibrosis



HCV genotype does not predict sustained virologic response to interferon plus ribavirin in chronic hepatitis C patients with advanced fibrosis



Journal of Hepatology 36(Suppl. 1): 230




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 035009200

Download citation: RISBibTeXText

DOI: 10.1016/s0168-8278(02)80826-1


Related references

Association between ribavirin plasma concentration and sustained virologic response in treatment of patients with genotype 1b chronic hepatitis C with pegylated interferon-α-2b and ribavirin. Zhonghua Gan Zang Bing Za Zhi 24(3): 175-180, 2017

Su1074 Meta-Analysis: Sustained Virologic Response (Svr) in Patients With Infection With Hepatitis C Virus Genotype 5 (Hcv-5) Versus Genotype 1 (Hcv-1) and Hcv Genotype 2/3 (Hcv -2/3) Treated With Interferon (Ifn) or Pegylated Interferon and Ribavirin (Peg Ifn+Rbv). Gastroenterology 146(5): S-981-S-982, 2014

W1005 Hcv Rna At 12 Weeks After Treatment Can Predict Sustained Virologic Response in Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin. Gastroenterology 134(4): A-830, 2008

Protein Pathway Biomarkers Predicting Sustained Virologic Response (Svr) to Pegylated Interferon (Peg-Ifn) and Ribavirin (Rbv) in Treatment-Naive Genotype 1 Patients With Chronic Hepatitis C (Ch-C). Gastroenterology 138(5): S-783, 2010

PEG-INTERFERON alpha-2B + RIBAVIRIN FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C WHO HAVE PREVIOUSLY FAILED TO ACHIEVE A SUSTAINED VIROLOGIC RESPONSE FOLLOWING INTERFERON ALFA OR INTERFERON A-2B + RIBAVIRIN THERAPY. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No T1292, 2003

Absence of sustained virologic response to interferon plus ribavirin in genotype 2/3 chronic hepatitis C patients with elevated serum ferritin and H63D or C282Y HFE gene mutations. Hepatology 38(4 Suppl 1): 748A-749A, 2003

A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate. Clinical Infectious Diseases 58(1): 130-133, 2014

Early virologic response value as predictive factor of sustained virologic response to treatment with interferon alpha-2b plus ribavirin in chronic hepatitis C patients with or without HIV coinfection. Medicina Clinica 127(15): 561-566, 2006

Comparison of early virologic response among patients with chronic hepatitis C infected with genotype non 2/3 treated with pegylated interferon alfa-2B and ribavirin in dependence with hepatic fibrosis stages. Przeglad Epidemiologiczny 60(4): 673-676, 2007

Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C. Journal of Hepatology 40(Suppl 1): 150, 2004

Meta-Analysis: Sustained Virologic Response (Svr) in Asian Patients With Infection With Hepatitis C Virus Genotype 6 (Hcv-6) Versus Genotype 1 (Hcv-1) Treated With Pegylated Interferon and Ribavirin (Peg Ifn+Rbv) for 48 Weeks. Gastroenterology 146(5): S-921-S-922, 2014

PEG-interferon alpha2B plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alpha or interferon alpha-2B plus ribavirin therapy. Hepatology 34(4 Pt 2): 419A, 2001

Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients. Hepatology International 9(3): 431-437, 2016

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology 59(1): 193-194, 2014

Prospective evaluation of the 24 hour interferon induced decline in hepatitis C virus genotype 1 load to predict sustained virologic response to peginterferon-alfa2a/ribavirin combination therapy with or without amantadine. Journal of Hepatology 40(Suppl 1): 141, 2004